The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


Oncolytics Biotech Inc down slightly

Oncolytics Biotech Inc closed down just $0.00 Wednesday to $0.30. Over the last five days, shares have lost 6.25% and are down 22.08% for the last year to date. This security has underperformed the S&P TSX by 53.80% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.11
Updated October 26 3:59 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense3443
Selling / general / administrative0000
Research & development2322
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total1111
Operating income-3-4-4-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax-3-4-3-3
Income after tax-3-4-3-3
Income tax, total0000
Net income-3-4-3-3
Total adjustments to net income--------
Net income before extra. items-3-4-3-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-3-4-3-3
Inc. avail. to common incl. extra. items-3-4-3-3
Diluted net income-3-4-3-3
Dilution adjustment0000
Diluted weighted average shares120118118118
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.03-0.03-0.02
Dividends per sharevalue per share0.
Diluted normalized EPSvalue per share-0.02-0.03-0.03-0.02